---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-009584"
form_type: "8-K"
ticker: "FTLF"
cik: "0001374328"
company_name: "FITLIFE BRANDS, INC."
filed_at: "2025-03-27T23:59:59+00:00"
generated_at: "2026-05-24T03:48:07.733922+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# FitLife Q4 rev +13% to $15M; FY24 adj EBITDA +39% to $14.1M; Q1 2025 rev seen -4-6%

## Summary
- Q4 2024 revenue $15.0M (+13% YoY), net income $2.1M ($0.21 diluted EPS), adjusted EBITDA $3.1M (+31%).
- FY24 revenue $64.5M (+22%), net income $9.0M (+70%), adj EBITDA $14.1M (+39%); net debt $8.6M (0.6x adj EBITDA).
- GNC commercial dispute settled Jan 2025; Legacy FitLife Q4 wholesale down 20% due to order halt, now selling directly to franchisees.
- MusclePharm Q4 revenue $2.8M (+14% seq); launched Pro Series at Vitamin Shoppe and new RTD protein; rebranding underway.
- Q1 2025 prelim: revenue down 4-6% YoY (MRC seasonality, leap year), adj EBITDA flat; China tariffs may raise COGS, mitigating via raw material stockpiling.

## SEC filing metadata
- accession: 0001437749-25-009584
- form_type: 8-K
- ticker: FTLF
- cik: 0001374328
- company_name: FITLIFE BRANDS, INC.
- filed_at: 2025-03-27T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1374328/000143774925009584/0001437749-25-009584-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1374328/000143774925009584/ftlf20250327_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-009584
- JSON: https://secwatch.observer/filing/0001437749-25-009584.json
- Plain text: https://secwatch.observer/filing/0001437749-25-009584.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.